Long-term secondary prevention of cardiovascular disease with a Mediterranean diet and a low-fat diet (CORDIOPREV): a randomised controlled trial
Open accessThe DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
Abstract
Background Mediterranean and low-fat diets are effective in the primary prevention of cardiovascular disease. We did a long-term randomised trial to compare the effects of these two diets in secondary prevention of cardiovascular disease.Methods The CORDIOPREV study was a single-centre, randomised clinical trial done at the Reina Sofia University Hospital in Córdoba, Spain. Patients with established coronary heart disease (aged 20-75 years) were randomly assigned in a 1:1 ratio by the Andalusian School of Public Health to receive a Mediterranean diet or a low-fat diet intervention, with a follow-up of 7 years. Clinical investigators (physicians, investigators, and clinical endpoint committee members) were masked to treatment assignment; participants were not. A team of dietitians did the dietary interventions. The primary outcome (assessed by intention to treat) was a composite of major cardiovascular events, including myocardial infarction, revascularisation, ischaemic stroke, peripheral artery disease, and cardiovascular death. This study is registered with ClinicalTrials.gov, NCT00924937.Findings From Oct 1, 2009, to Feb 28, 2012, a total of 1002 patients were enrolled, 500 (49·9%) in the low-fat diet group and 502 (50·1%) in the Mediterranean diet group. The mean age was 59·5 years (SD 8·7) and 827 (82·5%) of 1002 patients were men. The primary endpoint occurred in 198 participants: 87 in the Mediterranean diet group and 111 in the low-fat group (crude rate per 1000 person-years: 28·1 [95% CI 27·9-28·3] in the Mediterranean diet group vs 37·7 [37·5-37·9] in the low-fat group, log-rank p=0·039). Multivariable-adjusted hazard ratios (HRs) of the different models ranged from 0·719 (95% CI 0·541-0·957) to 0·753 (0·568-0·998) in favour of the Mediterranean diet. These effects were more evident in men, with primary endpoints occurring in 67 (16·2%) of 414 men in the Mediterranean diet group versus 94 (22·8%) of 413 men in the low-fat diet group (multiadjusted HR 0·669 [95% CI 0·489-0·915], log-rank p=0·013), than in 175 women for whom no difference was found between groups.Interpretation In secondary prevention, the Mediterranean diet was superior to the low-fat diet in preventing major cardiovascular events. Our results are relevant to clinical practice, supporting the use of the Mediterranean diet in secondary prevention.Funding Fundacion Patrimonio Comunal Olivarero; Fundacion Centro para la Excelencia en Investigacion sobre Aceite de Oliva y Salud; local, regional, and national Spanish Governments; European Union.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Besides macronutrient composition, overall healthy eating behavior may be relevant, as Mediterranean diets showed beneficial effects on liver lipid content and non-invasive markers of MASLD [62,63], but also on type 2 diabetes [64] and cardiovascular outcomes [65].”
From Obesity and MASLD: Is weight loss the (only) key to treat metabolic liver disease? (2024) · cites this paper as [65]
In the citing paper
“To date, improvements in dietary quality rather than restrictive dietary counseling have shown benefits in primary and secondary CVD prevention,98,99”
From Malnutrition and Cachexia in Inpatients With Acute Cardiac Conditions: A Scientific Statement From the American Heart Association (2026) · cites this paper as [98]
In the citing paper
“A shift from a more animal-based to a plant-based food pattern may also reduce ASCVD risk.[83][84][85]”
From 2023 ESC guidelines for the management of cardiovascular disease in patients with diabetes. (2023) · cites this paper as [85]
Citations
Cites
1 retracted
RETRACTED: Primary Prevention of Cardiovascular Disease with a Mediterranean Diet
Estruch, R., Ros, E., Salas-Salvadó, J., Covas, M.-I., Corella, D., Arós, F., Gómez-Gracia, E., Ruiz-Gutiérrez, V., Fiol, M., Lapetra, J., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1200303 · Cited by 4,257
Self-citationRetractedGrundy, S. M., Bilheimer, D. W., Chait, A., Clark, L. T., Denke, M. A., Havel, R. J., Hazzard, W. R., Hulley, S. B., Hunninghake, D. B., Kreisberg, R. A., et al. (1993) · JAMA · doi:10.1001/jama.269.23.3015 · Cited by 27,947
Mach, F., Baigent, C., Catapano, A. L., Koskinas, K. C., Casula, M., Badimon, L., Chapman, M. J., De Backer, G. G., Delgado, V., Ference, B. A., et al. (2020) · European Heart Journal · doi:10.1093/eurheartj/ehz455 · Cited by 8,961
Evolocumab and Clinical Outcomes in Patients with Cardiovascular Disease
Sabatine, M. S., Giugliano, R. P., Keech, A. C., Honarpour, N., Wiviott, S. D., Murphy, S. A., Kuder, J. F., Wang, H., Liu, T., Wasserman, S. M., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1615664 · Cited by 6,138 · cited 2×
“33,34 The fact that primary endpoint rates were lower than expected might support the hypothesis that the two diets had high efficacy in preventing cardiovascular recurrences and support the previous results of studies with low-fat diet versus control diets, 3–10 or with the Mediterranean diet in…”
Mach, F., Baigent, C., Catapano, A. L., Koskinas, K. C., Casula, M., Badimon, L., Chapman, M. J., De Backer, G. G., Delgado, V., Ference, B. A., et al. (2019) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2019.08.014 · Cited by 4,854
Ezetimibe Added to Statin Therapy after Acute Coronary Syndromes
Cannon, C. P., Blazing, M. A., Giugliano, R. P., McCagg, A., White, J. A., Theroux, P., Darius, H., Lewis, B. S., Ophuis, T. O., Jukema, J. W., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1410489 · Cited by 4,487 · cited 1×
“33,34 The fact that primary endpoint rates were lower than expected might support the hypothesis that the two diets had high efficacy in preventing cardiovascular recurrences and support the previous results of studies with low-fat diet versus control diets, 3–10 or with the Mediterranean diet in…”
Estruch, R., Ros, E., Salas-Salvadó, J., Covas, M.-I., Corella, D., Arós, F., Gómez-Gracia, E., Ruiz-Gutiérrez, V., Fiol, M., Lapetra, J., et al. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1800389 · Cited by 3,616 · cited 3×
“13 However, despite epidemiological and mechanistic studies showing similar results, 14–21 no evidence from large-scale, long-term clinical trials exists on the efficacy of the Mediterranean diet on secondary cardiovascular prevention, especially when compared with another active group.”
Self-citationde Lorgeril, M., Salen, P., Martin, J.-L., Monjaud, I., Delaye, J., & Mamelle, N. (1999) · Circulation · doi:10.1161/01.cir.99.6.779 · Cited by 2,910 · cited 2×
“Another review analysing the effect of the Mediterranean diet 30 highlights the need for new data on secondary prevention, as the only two significant existing studies were either too short 28 or show some concerns.”
Burr, M. L., Gilbert, J. F., Holliday, R. M., Elwood, P. C., Fehily, A. M., Rogers, S., Sweetnam, P. M., & Deadman, N. M. (1989) · The Lancet · doi:10.1016/s0140-6736(89)90828-3 · Cited by 2,610 · cited 1×
“…lower than expected might support the hypothesis that the two diets had high efficacy in preventing cardiovascular recurrences and support the previous results of studies with low-fat diet versus control diets, 3–10 or with the Mediterranean diet in participants at high risk in primary prevention.”
Cited by
KDIGO 2024 clinical practice guideline for the evaluation and management of chronic kidney disease
Stevens, P. E., Ahmed, S. B., Carrero, J. J., Foster, B., Francis, A., Hall, R. K., Herrington, W. G., Hill, G., Inker, L. A., Kazancıoğlu, R., et al. (2024) · Kidney International · doi:10.1016/j.kint.2023.10.018 · Cited by 8,530
2023 ESC Guidelines for the management of acute coronary syndromes
Byrne, R. A., Rossello, X., Coughlan, J. J., Barbato, E., Berry, C., Chieffo, A., Claeys, M. J., Dan, G.-A., Dweck, M. R., Galbraith, M., et al. (2023) · European Heart Journal · doi:10.1093/eurheartj/ehad191 · Cited by 5,333
2024 ESC Guidelines for the management of elevated blood pressure and hypertension
McEvoy, J. W., McCarthy, C. P., Bruno, R. M., Brouwers, S., Canavan, M. D., Ceconi, C., Christodorescu, R. M., Daskalopoulou, S. S., Ferro, C. J., Gerdts, E., et al. (2024) · European Heart Journal · doi:10.1093/eurheartj/ehae178 · Cited by 2,298
“274 Accordingly, evidence-based diets such as the Mediterranean diet and the DASH diet are established interventions in patients with hypertension to reduce their BP and CVD risk.”
2023 ESC guidelines for the management of cardiovascular disease in patients with diabetes.
Marx, N., Federici, M., Schütt, K., Müller-Wieland, D., Ajjan, R. A., Antunes, M. J., Christodorescu, R. M., Crawford, C., Di Angelantonio, E., Eliasson, B., et al. (2023) · European Heart Journal · doi:10.1093/eurheartj/ehad192 · Cited by 1,642
Type 2 diabetes mellitus in adults: pathogenesis, prevention and therapy
Lu, X., Xie, Q., Pan, X., Zhang, R., Zhang, X., Peng, G., Zhang, Y., Shen, S., & Tong, N. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01951-9 · Cited by 665
Metadata
- Authors
- Delgado-Lista, J., Alcala-Diaz, J. F., Torres-Peña, J. D., Quintana-Navarro, G. M., Fuentes, F., Garcia-Rios, A., Ortiz-Morales, A. M., Gonzalez-Requero, A. I., Perez-Caballero, A. I., Yubero-Serrano, E. M., Rangel-Zuñiga, O. A., Camargo, A., Rodriguez-Cantalejo, F., Lopez-Segura, F., Badimon, L., Ordovas, J. M., Perez-Jimenez, F., Perez-Martinez, P., Lopez-Miranda, J., Alcala-Diaz, J. F., Almaden Peña, Y., Aranda, E., Arenas de Larriva, A. P., Badimon, L., Badimon, J. J., Blanco-Molina, A., Blanco-Rojo, R., Bolivar-Muñoz, J., Caballero-Villarraso, J., Camargo, A., Chica, J., Corina, A., Criado-Garcia, J., Cruz-Teno, C., Daponte-Codina, A., de Teresa Galvan, E., Delgado-Casado, N., Delgado-Lista, J., Estruch, R., Fernandez, J. M., Fernandez-Gandara, C., Fuentes-Jimenez, F., Garcia-Carpintero Fernandez-Pacheco, S., Garcia-Rios, A., Gomez-Delgado, F., Gomez-Garduño, A., Gomez-Luna, P., Gomez-Luna, M. J., Gonzalez-Guardia, L., Gonzalez-Requero, A. I., Gutierrez-Mariscal, F. M., Haro-Mariscal, C. M., Jimenez-Lucena, R., Jimenez-Morales, A. I., Leon-Acuña, A., Lopez-Miranda, J., Lopez-Segura, F., Marin-Hinojosa, C., Meneses Alvarez, M. E., Mesa-Luna, D., Moya-Garrido, M. N., Muñoz-Carvajal, I., Navarro-Martos, V., Ochoa, J. J., Ordovas, J. M., Ortiz-Minuesa, J. A., Ortiz-Morales, A. M., Pan, M., Peña-Orihuela, P., Perez-Caballero, A. I., Perez-Corral, I., Perez-Jimenez, F., Perez-Martinez, P., Pi-Sunyer, F. X., Quintana-Navarro, G. M., Ramirez-Lara, I., Rangel-Zuñiga, O. A., Rodriguez-Artalejo, F., Rodriguez-Cantalejo, F., Romero, M. A., Roncero-Ramos, I., Ruano-Ruiz, J. A., Ruiz de Castroviejo, J., Sanchez-Villegas, P., Suarez de Lezo, J., Suarez de Lezo, J., Torres-Peña, J. D., Vals-Delgado, C., Valverde, R., Visioli, F., & Yubero-Serrano, E. M.
- Affiliations
- Instituto de Salud Carlos III (ES)
- Venue
- The Lancet
- Publisher
- Elsevier BV
- Published
- 2022-05
- Volume
- 399
- Issue
- 10338
- Pages
- 1876-1885
- ISSN
- 0099-5355 (ISSN-L)
- 0140-6736
- OpenAlex
- W4229029536
- Cited by
- 642
- References
- 35
- Citations by year
- 2026: 141 · 2025: 153 · 2024: 190 · 2023: 114 · 2022: 43
- FWCI
- 110.59
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- www.elsevier.com/open-access/userlicense/1.0/ (am, 368 d)
- doi.org/10.15223/policy-017 (stm-asf)
- doi.org/10.15223/policy-037 (stm-asf)
- doi.org/10.15223/policy-012 (stm-asf)
- doi.org/10.15223/policy-029 (stm-asf)
- doi.org/10.15223/policy-004 (stm-asf)
- Locations
- The Lancet (acceptedVersion)
- PubMed (publishedVersion)
- Universidad de Córdoba Insitutional Repository (Universidad de Córdoba) (submittedVersion, cc-by-nc-nd)
- Padua Research Archive (University of Padova) (submittedVersion)
- Funders
- Fundacion Patrimonio Comunal Olivarero
- Government of Andalusia Ministry of Economy Science Innovation and Employment (CVI-7450, P20_00256)
- Ministerio de Economía y Competitividad (PCIN-2016-084, AGL2015-67896-P, AGL2012/39615, AGL2009-122270)
- Sanofi
- European Regional Development Fund
- Boehringer Ingelheim España
- Amgen
- U.S. Department of Agriculture (8050-51000-098-00D)
- Ministerio de Ciencia e Innovación (FIS PI10/01041, FIS PI13/00023, PI10/02412, PI13/00619, PI10/01041, DTS19/00007, PIE14/00005, PI19/00299, PI15/00733, PI16/01777, PID2019-104362RB-I00, PIE 14/00031)
- Regional Government of Andalucia Department of Health and Families (PI-0058/10, PI-0170-2018-FIB, PI-0206-2013, PI0193/09, PC-0283-2017)
- Gobierno de Espana Ministerio de Medio Ambiente y Medio Rural y Marino
- Seventh Framework Programme (289511)
- Instituto de Salud Carlos III (PI18/01822, PI13/00023, CM12/00202, CP19/00142, CP14/00114, CPII19/00007, RD16/0011/0018)
- Mylan (PI13/00185)
- Ministério do Meio Ambiente
- Center for East Asian Studies, Stanford University
- Servicio Andaluz de Salud (B-0009-2017, B-00009-2017)
- Bayer
- Federación Española de Enfermedades Raras
- Meso Scale Diagnostics
- Novo Nordisk
- Junta de Andalucía
- Topics
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Nutritional Studies and Diet
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Health and Risk Factors
- Health Sciences › Nursing › Nutrition and Dietetics › Fatty Acid Research and Health
- Keywords
- Mediterranean diet, low-fat diet, secondary prevention, cardiovascular disease, coronary artery disease, major adverse cardiovascular events, myocardial infarction, ischemic stroke, cardiovascular mortality, dietary intervention, sex differences, long-term follow-up, revascularization, peripheral arterial disease, cardiovascular risk factors, LDL cholesterol, triglycerides, HDL cholesterol, blood pressure
- MeSH terms
- Cardiovascular Diseases, Brain Ischemia, Female, Humans, Male, Middle Aged, Diet, Fat-Restricted, Stroke, Diet, Mediterranean, Secondary Prevention
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Long-term secondary prevention of cardiovascular disease with a Mediterranean diet and a low-fat diet (CORDIOPREV): a randomised controlled trial. https://app.cochat.ai/papers/10.1016/s0140-6736(22)00122-2
- The paper
- Delgado-Lista, J., Alcala-Diaz, J. F., Torres-Peña, J. D., Quintana-Navarro, G. M., Fuentes, F., Garcia-Rios, A., Ortiz-Morales, A. M., Gonzalez-Requero, A. I., Perez-Caballero, A. I., Yubero-Serrano, E. M., Rangel-Zuñiga, O. A., Camargo, A., Rodriguez-Cantalejo, F., Lopez-Segura, F., Badimon, L., Ordovas, J. M., Perez-Jimenez, F., Perez-Martinez, P., Lopez-Miranda, J., . . . Yubero-Serrano, E. M. (2022). Long-term secondary prevention of cardiovascular disease with a Mediterranean diet and a low-fat diet (CORDIOPREV): a randomised controlled trial. The Lancet. https://doi.org/10.1016/s0140-6736(22)00122-2
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.